Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs-Reference-Cited by-同舟云学术

Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs

Published:2016-11 Issue: Volume:42 Page:29-37
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Brigo Francesco^ORCID,Bragazzi Nicola Luigi,Nardone Raffaele,Trinka Eugen

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference49 articles.

1. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach;Ngugi;Epilepsia,2010

2. Drug-resistant epilepsy;Kwan;N Engl J Med,2011

3. Patterns of treatment response in newly diagnosed epilepsy;Brodie;Neurology,2012

4. Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients;Trinka;Acta Neurol Scand Suppl,2012

5. New antiepileptic medication linked to blue discoloration of the skin and eyes;Clark;Ther Adv Drug Saf,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mirror, Mirror on the Wall, Who’s the Fairest Third Generation Anti-Seizure Medication of All?;Epilepsy Currents;2024-02-20

2. Efficacy, tolerability and safety of perampanel in population with pharmacoresistant focal seizures: A systematic review and meta-analysis;Epilepsy Research;2022-05

3. Pharmakotherapie der Epilepsie;psychopraxis. neuropraxis;2022-02-23

4. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis;Drugs;2022-01-21

5. Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide;Therapeutic Advances in Neurological Disorders;2022-01